Comparing Dosimetry Considerations Across Alpha & Beta Emitters to Inform Therapeutic Development
2:00 pm - Thursday 25th February 2027
- Benchmark the current state of therapeutic radiopharmaceutical dosimetry to understand what can reliably be measured today & where critical uncertainties remain
- Examine current regulatory expectations & the limitations of existing dose thresholds to determine what evidence is needed for therapeutic radiopharmaceutical development
- Explore the path towards more standardized dosimetry approaches that can better connect absorbed dose with clinical outcomes & inform therapeutic development
